Presentation is loading. Please wait.

Presentation is loading. Please wait.

Kaplan-Meier analysis for the MACE-free or VA-free survival in patients with definite CS (A and C) or suspected CS (B and D) stratified by localisation.

Published byGilbert Wilkinson Modified over 5 years ago

Similar presentations

Presentation on theme: "Kaplan-Meier analysis for the MACE-free or VA-free survival in patients with definite CS (A and C) or suspected CS (B and D) stratified by localisation."— Presentation transcript:

1 Kaplan-Meier analysis for the MACE-free or VA-free survival in patients with definite CS (A and C) or suspected CS (B and D) stratified by localisation score. Kaplan-Meier analysis for the MACE-free or VA-free survival in patients with definite CS (A and C) or suspected CS (B and D) stratified by localisation score. Lower group, solid line; higher group, dotted line. CS, cardiac sarcoidosis; MACE, major adverse cardiac event; VA, ventricular tachyarrhythmia. Masakazu Yasuda et al. Open Heart 2016;3:e000437 ©2016 by British Cardiovascular Society

Download ppt "Kaplan-Meier analysis for the MACE-free or VA-free survival in patients with definite CS (A and C) or suspected CS (B and D) stratified by localisation."

Similar presentations

 Kaplan-Meier survival curves by frequency of exacerbations in patients with COPD: group A, patients with no acute exacerbations of COPD; group B, patients.

 Kaplan-Meier survival curves by frequency of exacerbations in patients with COPD: group A, patients with no acute exacerbations of COPD; group B, patients.
Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.

Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.
Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.

Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.
Noriko Kikuchi et al. JACEP 2016;2:

Noriko Kikuchi et al. JACEP 2016;2:
Age-related cumulative incidence for (A) serious adverse events (including death, heart failure admission, ventricular arrhythmia and cardiac transplant)

Age-related cumulative incidence for (A) serious adverse events (including death, heart failure admission, ventricular arrhythmia and cardiac transplant)
Kaplan-Meier survival curves comparing survival between both time periods according to management strategy. Survival in patients with infective endocarditis.

Kaplan-Meier survival curves comparing survival between both time periods according to management strategy. Survival in patients with infective endocarditis.
MACE rate among CAD severity groups (total 0

MACE rate among CAD severity groups (total 0
Leonardo P. de Carvalho et al. BTS 2018;3:

Leonardo P. de Carvalho et al. BTS 2018;3:
David F. Katz et al. JACEP 2016;j.jacep

David F. Katz et al. JACEP 2016;j.jacep
David Badrudin, MD, Feras Khaliel, MD, Raymond Cartier, MD 

David Badrudin, MD, Feras Khaliel, MD, Raymond Cartier, MD 
Mohit K. Turagam et al. JACEP 2017;3:

Mohit K. Turagam et al. JACEP 2017;3:
Kaplan-Meier curves comparing: (A) overall survival for patients treated on trial compared to those outside of a trial; (B) progression-free survival for.

Kaplan-Meier curves comparing: (A) overall survival for patients treated on trial compared to those outside of a trial; (B) progression-free survival for.
Kaplan-Meier curves: revascularisation rate (PCI or CABG) was significantly higher (p

Kaplan-Meier curves: revascularisation rate (PCI or CABG) was significantly higher (p
Svend A. Mortensen et al. JCHF 2014;2:

Svend A. Mortensen et al. JCHF 2014;2:
C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization  Patrick A. Stone,

C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization  Patrick A. Stone,
David F. Katz et al. JACEP 2017;3:20-28

David F. Katz et al. JACEP 2017;3:20-28
Kaplan-Meier estimate of mortality in 1798 propensity score matched pairs with a propensity score >0.5 for the whole observational period. Kaplan-Meier.

Kaplan-Meier estimate of mortality in 1798 propensity score matched pairs with a propensity score >0.5 for the whole observational period. Kaplan-Meier.
(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.

(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.
Long-term results estimates for patients with anomalous origin of coronary artery from the pulmonary artery, showing survival, freedom from coronary and.

Long-term results estimates for patients with anomalous origin of coronary artery from the pulmonary artery, showing survival, freedom from coronary and.
Cumulative survival without events during 1 year in patients with preserved systolic function (left ventricular ejection fraction (LVEF) >40%) and with.

Cumulative survival without events during 1 year in patients with preserved systolic function (left ventricular ejection fraction (LVEF) >40%) and with.

Similar presentations

Ads by Google